Literature DB >> 3091176

The acquired immune deficiency syndrome and epidemic of infection with human immunodeficiency virus: costs of care and prevention in an inner London district.

A M Johnson, M W Adler, J M Crown.   

Abstract

The epidemic of the acquired immune deficiency syndrome (AIDS) and infection with human immunodeficiency virus (HIV) necessitates early planning of services and allocation of resources. The use of hospital resources by patients with AIDS and the planned additional costs of clinical and preventive services for the epidemic of infection with HIV were calculated for an inner London health district that has treated 18% of the cases in the United Kingdom. Patients with AIDS required on average 50 days of inpatient hospital care each at an estimated current average lifetime cost of pounds 6800. These costs, however, underestimated the additional capital and revenue costs of planned new preventive and treatment services, estimated as being pounds 388,000 revenue and pounds 472,000 capital for 1986-7. It is important to invest now in preventive services throughout the United Kingdom to reduce the future social and financial costs of AIDS.

Entities:  

Mesh:

Year:  1986        PMID: 3091176      PMCID: PMC1341122          DOI: 10.1136/bmj.293.6545.489

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  17 in total

1.  Estimating the prevalence of opioid dependence.

Authors:  R Hartnoll; R Lewis; M Mitcheson; S Bryer
Journal:  Lancet       Date:  1985-01-26       Impact factor: 79.321

2.  HTLV-III antibody in Swiss and English intravenous drug abusers.

Authors:  P P Mortimer; E M Vandervelde; W J Jesson; M S Pereira; F Burkhardt
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

3.  Pulmonary complications of the acquired immunodeficiency syndrome. Report of a National Heart, Lung, and Blood Institute workshop.

Authors:  J F Murray; C P Felton; S M Garay; M S Gottlieb; P C Hopewell; D E Stover; A S Teirstein
Journal:  N Engl J Med       Date:  1984-06-21       Impact factor: 91.245

4.  Epidemic of the acquired immunodeficiency syndrome: a need for economic and social planning.

Authors:  J E Groopman; A S Detsky
Journal:  Ann Intern Med       Date:  1983-08       Impact factor: 25.391

5.  Senile disciform macular degeneration: features indicating suitability for photocoagulation.

Authors:  R H Grey; A C Bird; I H Chisholm
Journal:  Br J Ophthalmol       Date:  1979-02       Impact factor: 4.638

6.  Prevalence of antibody to human T lymphotropic virus type III by risk group and area, United Kingdom 1978-84.

Authors:  P P Mortimer; W J Jesson; E M Vandervelde; M S Pereira
Journal:  Br Med J (Clin Res Ed)       Date:  1985-04-20

7.  Human T-cell lymphotropic virus type III infection in a cohort of homosexual men in New York City.

Authors:  C E Stevens; P E Taylor; E A Zang; J M Morrison; E J Harley; S Rodriguez de Cordoba; C Bacino; R C Ting; A J Bodner; M G Sarngadharan
Journal:  JAMA       Date:  1986-04-25       Impact factor: 56.272

8.  Rising prevalence of human T-lymphotropic virus type III (HTLV-III) infection in homosexual men in London.

Authors:  C A Carne; I V Weller; S Sutherland; R Cheingsong-Popov; R B Ferns; P Williams; A Mindel; R Tedder; M W Adler
Journal:  Lancet       Date:  1985-06-01       Impact factor: 79.321

9.  Acquired immunodeficiency syndrome (AIDS) associated with transfusions.

Authors:  J W Curran; D N Lawrence; H Jaffe; J E Kaplan; L D Zyla; M Chamberland; R Weinstein; K J Lui; L B Schonberger; T J Spira
Journal:  N Engl J Med       Date:  1984-01-12       Impact factor: 91.245

10.  The acquired immunodeficiency syndrome in a cohort of homosexual men. A six-year follow-up study.

Authors:  H W Jaffe; W W Darrow; D F Echenberg; P M O'Malley; J P Getchell; V S Kalyanaraman; R H Byers; D P Drennan; E H Braff; J W Curran
Journal:  Ann Intern Med       Date:  1985-08       Impact factor: 25.391

View more
  10 in total

Review 1.  Health economics in HIV disease. A review of the European literature.

Authors:  M Youle; P Trueman; K Simpson
Journal:  Pharmacoeconomics       Date:  1999       Impact factor: 4.981

2.  Care for patients with HIV infection and AIDS.

Authors:  M W Adler
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-04

3.  The economic costs of caring for people with HIV infection and AIDS in England and Wales.

Authors:  S Petrou; M Dooley; L Whitaker; E Beck; E Kupek; J Wadsworth; D Miller; A Renton
Journal:  Pharmacoeconomics       Date:  1996-04       Impact factor: 4.981

4.  Control of sexually transmitted diseases today and tomorrow.

Authors:  R S Morton
Journal:  Genitourin Med       Date:  1987-06

5.  AIDS: counting the cost.

Authors:  D Cunningham; S F Griffiths
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-10

Review 6.  The cost of HIV treatment and care. A global review.

Authors:  E J Beck; A H Miners; K Tolley
Journal:  Pharmacoeconomics       Date:  2001-01       Impact factor: 4.981

7.  The use and cost of HIV service provision in England in 1996. National Prospective Monitoring System (NPMS) Steering Group and NPMS Working Party on Costs.

Authors:  E J Beck; K Tolley; A Power; S Mandalia; P Rutter; J Izumi; J Beecham; A Gray; D Barlow; P Easterbrook; M Fisher; J Innes; G Kinghorn; B Mandel; A Pozniak; A Tang; D Tomlinson; I Williams
Journal:  Pharmacoeconomics       Date:  1998-12       Impact factor: 4.981

Review 8.  Universal precautions to prevent HIV transmission to health care workers: an economic analysis.

Authors:  S R Stock; A Gafni; R F Bloch
Journal:  CMAJ       Date:  1990-05-01       Impact factor: 8.262

9.  Human immunodeficiency virus in drug misusers and increased consultation in general practice.

Authors:  J J Roberts; C A Skidmore; J R Robertson
Journal:  J R Coll Gen Pract       Date:  1989-09

10.  Patterns of hospital care for patients with HIV infection and AIDS.

Authors:  A M Johnson; C Shergold; A Hawkins; R Miller; M W Adler
Journal:  J Epidemiol Community Health       Date:  1993-06       Impact factor: 3.710

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.